Table 1 Resistance rates to antimicrobials in E. faecalis isolates from urine and fecal specimens in patients with community acquired-UTIs
Antibiotics | Urine samples N = 63 (%) | Fecal samples N = 63 (%) | ||||
|---|---|---|---|---|---|---|
R | I | S | R | I | S | |
Ampicillin (10 µg) | 0 (0%) | – | 63 (100%) | 0 (0%) | – | 63 (100%) |
Penicillin G (10 units) | 0 (0%) | – | 63 (100%) | 0 (0%) | – | 63 (100%) |
Vancomycin (30 µg) | 0 (0%) | – | 63 (100%) | 0 (0%) | – | 63 (100%) |
Linezolide (30 µg) | 0 (0%) | – | 63 (100%) | 0 (0%) | – | 63 (100%) |
Nitrofurantoin (300 µg) | 0 (0%) | – | 63 (100%) | 0 (0%) | – | 63 (100%) |
Gatifloxacin (5 µg) | 8 (12.7%) | – | 55 (87.3%) | 4 (6.3%) | – | 59 (93.7%) |
Levofloxacin (5 µg) | 9 (14.3%) | – | 54 (85.7%) | 4 (6.3%) | – | 59 (93.7%) |
Ciprofloxacin (5 µg) | 13 (20.6%) | – | 50 (79.4%) | 8 (12.7%) | – | 55 (87.3%) |
Gentamycin (120 µg) | 18 (28.6%) | – | 45 (71.4%) | 10 (15.9%) | – | 53 (84.1%) |
Minocycline (30 µg) | 55 (87.3%) | – | 8 (12.7%) | 45 (71.4%) | – | 18 (28.6%) |
Tetracycline (30 µg) | 56 (88.9%) | – | 7 (11.1%) | 48 (76.2%) | – | 15 (23.8%) |
Daptomycin | 0 (0%) | – | 63 (100%) | 0 (0%) | – | 63 (100%) |